Apports des données en vie réelle à la sécurité des antipsychotiques chez l’enfant et l’adolescent
Authors:
- D.A. MerinoD.A. Merino
- A.O. GérardAGA.O. Gérard
- A. DestereADA. Destere
- F. AskenazyFAF. Askenazy
- F. MontastrucFMF. Montastruc
- M.-D. DriciMDM.-D. Drici
- S. ThümmlerSTS. Thümmler
Open Access
- 15 March 2025
- journal article
- Published by Elsevier in Neuropsychiatrie de l'Enfance et de l'Adolescence
- Vol. 73 (3) , 133-137
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Cardiac and metabolic safety profile of antipsychotics in youths: A WHO safety database analysisPsychiatry Research, 2024
- Drug-related catatonia in youths: real-world insights from the WHO Safety DatabaseEuropean Child & Adolescent Psychiatry, 2023
- Weight Gain During Antipsychotic Treatment in Children, Adolescents, and Adults: A Disproportionality Analysis in the Global Pharmacovigilance Database, Vigibase®Drug Safety, 2022
- Abuse and misuse of second‐generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance databaseBritish Journal of Clinical Pharmacology, 2022
- Real-World Data in the Postapproval Setting as Applied by the EMA and the US FDAClinical Therapeutics, 2022
- Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: Results of a multicenter naturalistic study (ETAPE)European Neuropsychopharmacology, 2019
- Off-Label Use of Clozapine in Children and Adolescents—A Literature ReviewAmerican Journal of Therapeutics, 2019
- Reported Adverse Drug Reactions in Children and Adolescents Treated with AntipsychoticsJournal of Child and Adolescent Psychopharmacology, 2019
- Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuseJournal of Substance Abuse Treatment, 2015
- Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and ChildrenNew England Journal of Medicine, 2003